A Randomized (1:1), Double-Blind, Multi-Center, Placebo Controlled Study Evaluating Intensive Chemotherapy With or Without Glasdegib (PF-04449913) or Azacitidine (AZA) With or Without Glasdegib in Patients with Previously Untreated Acute Myeloid Leukemia | UCI Health

Make a Gift
College of Health Sciences
Healthcare Professionals
Volunteering

MyChart Login
Clinical Trials
Career Opportunities
Contact Us

Home › Clinical Trials › Cancer Clinical Trial › Myeloid and Monocytic Leukemia › A Randomized (1:1), Double-Blind, Multi-Center, Placebo Controlled Study Evaluating Intensive Chemotherapy With or Without Glasdegib (PF-04449913) or Azacitidine (AZA) With or Without Glasdegib in Patients with Previously Untreated Acute Myeloid Leukemia

Print
A A A

COVID-19 vaccine and protecting your health ›